✦ LIBER ✦

Advancement of a drug-disease trial model for Alzheimer's disease through a regulatory science path: The CAMD experience

✍ Scribed by Romero, Klaus; Stephenson, Diane; Rogers, James; Polhamus, Dan; Ito, Kaori; Qiu, Ruolun; Corrigan, Brian

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The development of a data dictionary and

✍ Friedmann, Beth; Kingery, Lisle; Kornsey, Erin; Cutler, Neal; Riordan, Henry 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 54 KB

Experience with a Placebo-Controlled Ran

✍ Brandt, Kenneth D.; Mazzuca, Steven A. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 238 KB

Exebryl-1: A novel small molecule curren

✍ Snow, Alan D.; Cummings, Joel; Lake, Thomas; Hu, Qubai; Esposito, Luke; Cam, Jud 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 47 KB

A model for improving the treatment and

✍ John Q. Trojanowski; Steven E. Arnold; Jason H. Karlawish; Mary Naylor; Kurt R. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 602 KB

Measuring Memory in a Mouse Model of Alz

✍ Routtenberg;, A. 📂 Article 📅 1997 🏛 American Association for the Advancement of Scienc 🌐 English ⚖ 389 KB

A novel anticholinesterase THB013: A pos

✍ Adem, A.; Henriksson, B.; Islam, A.; Winblad, B.; Mohammed, A. 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 162 KB